Insights

Innovative Vaccine Development Intravacc specializes in bridging the gap between vaccine concepts and clinical trials, offering opportunities for partners seeking to accelerate their vaccine candidates into late-stage development and commercialization.

Focus on Critical Diseases With recent projects targeting gonorrhea and OMV-based intranasal vaccines, Intravacc presents potential for collaboration in developing solutions for antibiotic-resistant infections and emerging infectious diseases.

Strategic Funding Success Receiving $633,000 in CARB-X funding highlights Intravacc’s active role in innovative infectious disease research, providing avenues for partners interested in co-funding or supporting high-impact vaccine projects.

Recognition as Trusted Manufacturer Being named one of the most trusted vaccine manufacturing companies in 2023 positions Intravacc as a reliable partner for contract manufacturing and technology transfer opportunities.

Growth Potential in Biotech Sector Operating with a revenue range of $1 million to $10 million and an expert-focused team, Intravacc is well-positioned for expansion and partnerships within the biotech and pharmaceutical industries seeking innovative vaccine solutions.

Intravacc Tech Stack

Intravacc uses 8 technology products and services including HubSpot Analytics, TYPO3, WooCommerce, and more. Explore Intravacc's tech stack below.

  • HubSpot Analytics
    Analytics
  • TYPO3
    Content Management System
  • WooCommerce
    E-commerce
  • Font Awesome
    Font Scripts
  • Lightbox
    Javascript Libraries
  • Platform.sh
    Platform As A Service
  • Nginx
    Web Servers
  • X-UA-Compatible
    Web Tools And Plugins

Media & News

Intravacc's Email Address Formats

Intravacc uses at least 1 format(s):
Intravacc Email FormatsExamplePercentage
First.Last@intravacc.nlJohn.Doe@intravacc.nl
49%
First@intravacc.nlJohn@intravacc.nl
1%
First.Last@intravacc.nlJohn.Doe@intravacc.nl
49%
First@intravacc.nlJohn@intravacc.nl
1%

Frequently Asked Questions

Where is Intravacc's headquarters located?

Minus sign iconPlus sign icon
Intravacc's main headquarters is located at Antonie van Leeuwenhoeklaan 9, Bilthoven, Utrecht 3721 MA , NL. The company has employees across 2 continents, including EuropeNorth America.

What is Intravacc's official website and social media links?

Minus sign iconPlus sign icon
Intravacc's official website is intravacc.nl and has social profiles on LinkedInCrunchbase.

What is Intravacc's SIC code NAICS code?

Minus sign iconPlus sign icon
Intravacc's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Intravacc have currently?

Minus sign iconPlus sign icon
As of October 2025, Intravacc has approximately 62 employees across 2 continents, including EuropeNorth America. Key team members include Chief Operational Officer: D. L.Director Quality (qa/Qc) Regulatory And Ehs: P. B.Director: I. L.. Explore Intravacc's employee directory with LeadIQ.

What industry does Intravacc belong to?

Minus sign iconPlus sign icon
Intravacc operates in the Biotechnology Research industry.

What technology does Intravacc use?

Minus sign iconPlus sign icon
Intravacc's tech stack includes HubSpot AnalyticsTYPO3WooCommerceFont AwesomeLightboxPlatform.shNginxX-UA-Compatible.

What is Intravacc's email format?

Minus sign iconPlus sign icon
Intravacc's email format typically follows the pattern of First.Last@intravacc.nl. Find more Intravacc email formats with LeadIQ.

How much funding has Intravacc raised to date?

Minus sign iconPlus sign icon
As of October 2025, Intravacc has raised $633K in funding. The last funding round occurred on Jan 11, 2024 for $633K.

When was Intravacc founded?

Minus sign iconPlus sign icon
Intravacc was founded in 2013.

Intravacc

Biotechnology ResearchNetherlands51-200 Employees

Even the most promising vaccines don’t always make it out of the laboratory into large-scale production.  We at Intravacc are fully aware of the challenges on the long road of vaccine development.
We substantially reduce the risks and costs involved with developing vaccines. How? By bridging the gap between your concept and late stage clinical studies.
As an established independent CDMO in the vaccine industry, Intravacc offers a wide range of expertise and is the bridge between your discovery and the start of your phase I/II clinical trials in humans.
Part of Utrecht Science Park Bilthoven

Section iconCompany Overview

Headquarters
Antonie van Leeuwenhoeklaan 9, Bilthoven, Utrecht 3721 MA , NL
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2013
Employees
51-200

Section iconFunding & Financials

  • $633K

    Intravacc has raised a total of $633K of funding over 2 rounds. Their latest funding round was raised on Jan 11, 2024 in the amount of $633K.

  • $1M$10M

    Intravacc's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $633K

    Intravacc has raised a total of $633K of funding over 2 rounds. Their latest funding round was raised on Jan 11, 2024 in the amount of $633K.

  • $1M$10M

    Intravacc's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.